NasdaqCM - Nasdaq Real Time Price USD

Dominari Holdings Inc. (DOMH)

2.0500 -0.0600 (-2.84%)
At close: May 13 at 4:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Anthony C. Hayes Esq. CEO & Chairman 1M -- 1968
Mr. Kyle Michael Wool President & Director 600.36k -- 1978
Mr. George Michael Way CPA Chief Financial Officer -- -- 1968
Mr. Christopher Devall Chief Operating Officer 350k -- 1983
Mr. Matthew B. McCullough General Counsel -- -- 1986
Mr. Jaime Mercado Jr. Chief Compliance Officer -- -- --

Dominari Holdings Inc.

725 5th Avenue
22nd Floor
New York, NY 10022
United States
212-393-4540 https://www.dominariholdings.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
26

Description

Dominari Holdings Inc., through its subsidiaries, is engaged in wealth management, investment banking, sales and trading, and asset management. It operates through two segments: Dominari Financial and Legacy AIkido. It offers full-service brokerage services, including exchange-traded and over-the-counter corporate equity and debt securities, money market instruments, exchange-traded options, municipal bonds, mutual funds, exchange-traded funds, and unit investment trusts; financial and wealth planning services, such as asset management, individual and corporate retirement solutions, insurance and annuity products, IRAs and 401(k) plans, U.S. stock plan services, education savings programs, and trust and fiduciary services; and margin lending services. The company also provides financial advisory services to buyers and sellers on sales, divestitures, mergers, acquisitions, tender offers, privatizations, spin-offs, joint ventures, restructurings, and liability management; capital raising solutions through initial public offerings, follow-on offerings, confidentially marketed public offerings, registered directs, private investments in public equity, private placements, at-the-market offerings, and equity-linked offerings for corporate clients; institutional equity sales and trading; equity derivatives and index options; and trading in public and private debt securities, including investment and non-investment grade, distressed and convertible corporate securities. In addition, it offers asset management solutions, such as separately managed accounts, discretionary advisory accounts, non-discretionary advisory accounts, alternative investments, and private market platform. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.

Corporate Governance

Dominari Holdings Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Aug 07, 2024 - Aug 12, 2024
Dominari Holdings Inc. Earnings Call

Related Tickers

TMBRQ Trex Wind-down, Inc.
0.0002
0.00%
 
SILO Silo Pharma, Inc.
1.7700
+1.14%
 
PMN ProMIS Neurosciences, Inc.
2.0000
+5.82%
 
1GDA.F Zevra Therapeutics, Inc.
4.4800
+1.36%
 
ELTX Elicio Therapeutics, Inc.
9.65
+2.55%
 
CRPOF Ceapro Inc.
0.1830
0.00%
 
PPBT Purple Biotech Ltd
0.5200
+1.60%
 
NRXS NeurAxis, Inc.
3.0100
-7.10%
 
ENZN Enzon Pharmaceuticals, Inc.
0.0849
-2.10%
 
ANEB Anebulo Pharmaceuticals, Inc.
2.4100
-20.98%